Eleven Biotherapeutics Lands $35,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2b5b263c-a105-4c0e-92e0-a2124661f81d&Preview=1 -
Date
2/17/2010 -
Company Name
Eleven Biotherapeutics -
Mailing Address
790 Memorial Drive Cambridge, MA 02139 -
Company Description
Eleven Biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. -
Website
http://www.elevenbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$35,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The money and brainpower is being channeled into a company that seeks to engineer proteins with ideal properties for treating autoimmune diseases and blood clotting disorders. -
M&A Terms
-
Venture Investor
Third Rock Ventures -
Venture Investor
Flagship Ventures -
Venture Investor
Undisclosed
